These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 22124857)

  • 21. Prostate cancer detection in patients with total serum prostate-specific antigen levels of 4-10 ng/mL: diagnostic efficacy of diffusion-weighted imaging, dynamic contrast-enhanced MRI, and T2-weighted imaging.
    Tamada T; Sone T; Higashi H; Jo Y; Yamamoto A; Kanki A; Ito K
    AJR Am J Roentgenol; 2011 Sep; 197(3):664-70. PubMed ID: 21862809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.
    Haider MA; Chung P; Sweet J; Toi A; Jhaveri K; Ménard C; Warde P; Trachtenberg J; Lockwood G; Milosevic M
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):425-30. PubMed ID: 17881141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can the patient with cirrhosis be imaged for hepatocellular carcinoma without gadolinium?: Comparison of combined T2-weighted, T2*-weighted, and diffusion-weighted MRI with gadolinium-enhanced MRI using liver explantation standard.
    Hardie AD; Kizziah MK; Rissing MS
    J Comput Assist Tomogr; 2011; 35(6):711-5. PubMed ID: 22082541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic resonance evaluation of adnexal masses.
    Guerra A; Cunha TM; Félix A
    Acta Radiol; 2008 Jul; 49(6):700-9. PubMed ID: 18568564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRI of the thorax during whole-body MRI: evaluation of different MR sequences and comparison to thoracic multidetector computed tomography (MDCT).
    Frericks BB; Meyer BC; Martus P; Wendt M; Wolf KJ; Wacker F
    J Magn Reson Imaging; 2008 Mar; 27(3):538-45. PubMed ID: 18224677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of myocardial viability with contrast-enhanced magnetic resonance imaging--comparison of the late enhancement technique with positronemission tomography].
    Hunold P; Brandt-Mainz K; Freudenberg L; Vogt FM; Neumann T; Knipp S; Barkhausen J
    Rofo; 2002 Jul; 174(7):867-73. PubMed ID: 12101477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fat-saturated, contrast-enhanced spin-echo sequences in the magnetic resonance tomographic diagnosis of peritoneal carcinosis].
    Ricke J; Sehouli J; Hosten N; Stroszczynski C; Amthauer H; Rieger J; Buchmann E; Felix R
    Rofo; 1999 Dec; 171(6):461-7. PubMed ID: 10668511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative analysis of dynamic contrast enhanced MRI for assessment of bowel inflammation in Crohn's disease pilot study.
    Oto A; Fan X; Mustafi D; Jansen SA; Karczmar GS; Rubin DT; Kayhan A
    Acad Radiol; 2009 Oct; 16(10):1223-30. PubMed ID: 19524458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocellular carcinoma in liver transplantation candidates: detection with gadobenate dimeglumine-enhanced MRI.
    Choi SH; Lee JM; Yu NC; Suh KS; Jang JJ; Kim SH; Choi BI
    AJR Am J Roentgenol; 2008 Aug; 191(2):529-36. PubMed ID: 18647927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer.
    Ah-See ML; Makris A; Taylor NJ; Harrison M; Richman PI; Burcombe RJ; Stirling JJ; d'Arcy JA; Collins DJ; Pittam MR; Ravichandran D; Padhani AR
    Clin Cancer Res; 2008 Oct; 14(20):6580-9. PubMed ID: 18927299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance.
    Sardanelli F; Fausto A; Esseridou A; Di Leo G; Kirchin MA
    Invest Radiol; 2008 Apr; 43(4):236-42. PubMed ID: 18340247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic evaluation of chronic inflammatory intestinal diseases in children and adolescents: MRI with true-FISP as new gold standard?].
    Hohl C; Haage P; Krombach GA; Schmidt T; Ahaus M; Günther RW; Staatz G
    Rofo; 2005 Jun; 177(6):856-63. PubMed ID: 15902636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved preoperative evaluation of cerebral cavernomas by high-field, high-resolution susceptibility-weighted magnetic resonance imaging at 3 Tesla: comparison with standard (1.5 T) magnetic resonance imaging and correlation with histopathological findings--preliminary results.
    Pinker K; Stavrou I; Szomolanyi P; Hoeftberger R; Weber M; Stadlbauer A; Noebauer-Huhmann IM; Knosp E; Trattnig S
    Invest Radiol; 2007 Jun; 42(6):346-51. PubMed ID: 17507804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Additional value of gadoxetic acid-DTPA-enhanced hepatobiliary phase MR imaging in the diagnosis of early-stage hepatocellular carcinoma: comparison with dynamic triple-phase multidetector CT imaging.
    Haradome H; Grazioli L; Tinti R; Morone M; Motosugi U; Sano K; Ichikawa T; Kwee TC; Colagrande S
    J Magn Reson Imaging; 2011 Jul; 34(1):69-78. PubMed ID: 21598343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MRI scoring system including dynamic motility evaluation in assessing the activity of Crohn's disease of the terminal ileum.
    Girometti R; Zuiani C; Toso F; Brondani G; Sorrentino D; Avellini C; Bazzocchi M
    Acad Radiol; 2008 Feb; 15(2):153-64. PubMed ID: 18206614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [3D CISS, 3D MP-PAGE and 2D TSE for the preoperative MRI prior to cochlear implantation].
    Seitz J; Held P; Waldeck A; Völk M; Lenhart M; Strotzer M
    Rofo; 2000 Mar; 172(3):227-31. PubMed ID: 10778452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The value of dynamic MRI studies in parotid tumors.
    Alibek S; Zenk J; Bozzato A; Lell M; Grunewald M; Anders K; Rabe C; Iro H; Bautz W; Greess H
    Acad Radiol; 2007 Jun; 14(6):701-10. PubMed ID: 17502260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of fast dynamic imaging and the use of Gd-EOB-DTPA for MR-guided liver interventions.
    Fischbach F; Thormann M; Seidensticker M; Kropf S; Pech M; Ricke J
    J Magn Reson Imaging; 2011 Oct; 34(4):874-9. PubMed ID: 21769983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
    Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM
    AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of 1.0 M gadobutrol and 0.5 M gadopentetate dimeglumine-enhanced magnetic resonance imaging in five hundred seventy-two patients with known or suspected liver lesions: results of a multicenter, double-blind, interindividual, randomized clinical phase-III trial.
    Hammerstingl R; Adam G; Ayuso JR; Van Beers B; Belfiore G; Bellin MF; Bongartz G; Ernst O; Frericks B; Giuseppetti G; Heinz-Peer G; Laghi A; Martin J; Pering C; Reimer P; Richter GM; Roemer FW; Schäfer FK; Vilgrain V; Vogl TJ; Weishaupt D; Wall A; Zech CJ; Tombach B
    Invest Radiol; 2009 Mar; 44(3):168-76. PubMed ID: 19169143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.